A newly announced CMS policy to redistribute savings under the 340B Drug Discount Program so that Medicare beneficiaries save money on copayments has garnered a mixture of praise and criticism from supporters and critics of the program.
Established in 1992, the 340B program required drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at reduced prices.
CMS Finalizes Policies that Lower Out-of-Pocket Drug Costs and Increase Access to High-Quality Care [news release]. Baltimore, MD: CMS Newsroom; November 2, 2017. www.cms.gov/Newsroom/MediaReleaseDatabase/Press-releases/2017-Press-releases-items/2017-11-01-2.html.
... to read the full story